David R. Bauer
Lawyers
Filters
EquipmentShare $860 million IPO
We advised EquipmentShare on its IPO
AbelZeta sale of China rights to GPC3 CAR-T therapy to AstraZeneca
We advised AbelZeta on the transaction
Penumbra $14.5 billion sale to Boston Scientific
We are advising Penumbra on the transaction
Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026
W. L. Gore & Associates acquisition of Conformal Medical
We are advising Gore on the transaction
GSK strategic collaboration with CAMP4 Therapeutics
We advised GSK on the transaction
Kodiak Sciences $184 million stock offering
We advised the underwriters on the offering
Tenaya Therapeutics $60 million units offering
We advised the joint book-running managers and representatives of the several underwriters
Terns Pharmaceuticals $747.5 million stock offering
We advised the underwriters on the public offering
Denali Therapeutics $200 million stock and pre-funded warrants offering
We advised the representatives of the several underwriters on the offering